|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 19/00 | |
| C12N 15/62 | |||
| C12N 15/55 | |||
| C12N 15/85 | |||
| A61P 9/00 | |||
| C12N 9/22 | |||
| A61K 38/46 |
| (11) | Patento numeris | 2545080 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11754231.6 |
| Europos patento paraiškos padavimo data | 2011-03-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-01-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-05-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/028233 |
| Data | 2011-03-11 |
| (87) | Numeris | WO 2011/113027 |
| Data | 2011-09-15 |
| (30) | Numeris | Data | Šalis |
| 340066 P | 2010-03-12 | US |
| (72) |
QUINN, Anthony, US
HARVEY, Alex J., US
XIA, Zhinan, US
|
| (73) |
Alexion Pharmaceuticals, Inc.,
100 College Street, New Haven, CT 06510,
US
|
| (54) | NPP1 FUSION PROTEINS |
| NPP1 FUSION PROTEINS |